Search Results for: MBIO
Enochian Biosciences shares more than doubled to start out the week after the company received a critical update from the FDA regarding its HIV treatment.
Published:
Bio-Path stock has taken a beating in the past five years. Investors obviously aren’t happy about this, and the way that management and the board of directors has handled it has been clumsy.
Published:
Harbin Electric, Inc. (NASDAQ: HRBN) is going private, at least that is if the deal is accepted. The company has received a proposal letter from its Chairman and CEO, Mr. Tianfu Yang and Baring...
Published:
Last Updated:
While the late summer doldrums are here, the insider action since the end of the second-quarter earnings season is hardly dull.
Published:
Today was a crazy day for the markets, and as you’d expect there were many movers in the drug and biotech sectors. Today’s edition of the BioHealth Business Daily covers ARCA biopharma, Inc....
Published:
Last Updated:
Highlighted stocks include AbbVie and Eli Lilly.
Published:
Bio-Path shares made an incredible run on Wednesday after the company announced interim results from its mid-stage leukemia trial.
Published:
Last Updated:
Synthetic biology company Twist Bioscience expects to price 5 million shares for an initial public offering valued up to more than $103 million.
Published:
Last Updated:
Bluebird Bio saw its shares dip on Wednesday after the firm announced the pricing of a secondary offering of more than 3 million shares.
Published:
Last Updated:
PDL BioPharma, Inc. (NASDAQ: PDLI) appears to have a new royalty stream coming its way. The company announced this morning that it is now set to start receiving royalty payments from Roche’s...
Published:
Last Updated:
Eliot Spitzer, former prosecutor and now governor of New York State, will ape comments made by Deutsche Bank (DB) Chief Executive Josef Ackermann. If bond insurers fail its will create a...
Published:
Neurocrine Biosciences made waves in the market on Thursday morning after it announced positive results in a Phase 3 trial.
Published:
The head of Deutsche Bank (NYSE: DB) said the US could be driven into a deep recession if the muni insurace companies including MBIA (NYSE: MBI) and Ambac (NYSE: ABK) fail. The CEO said in an...
Published:
iBio has announced that it has selected a vaccine to advance for the prevention of infection by the coronavirus that causes COVID-19.
Published:
Goldman Sachs has maintained coverage of 2seventy bio with a Buy recommendation.
Published: